The Next Step of Their Control Is Here …

Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.

4 simple steps to protect your privacy and money before it’s too late.

ALZN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.86%

Insider Buying (Last 12 Months): $47,391.59

Insider Selling (Last 12 Months): $0.00

Alzamend Neuro Insider Trading History Chart

Alzamend Neuro Share Price & Price History

^$0.73

▲ +0.03 (4.27%)

As of 04/26/2024 01:00 AM ET

Days: 30 | 90 | 365

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

Alzamend Neuro Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/19/2024	Milton C. Ault III	Director	Buy	1,000	$0.69	$690.00	771,699
4/1/2024	Milton C. Ault III	Director	Buy	334	$0.91	$303.94	770,699
1/5/2024	Milton C. Ault III	Director	Buy	5,000	$1.02	$5,100.00	768,365
12/26/2023	Milton C. Ault III	Major Shareholder	Buy	500	$0.90	$450.00	26,032
12/22/2023	Milton C. Ault III	Major Shareholder	Buy	200	$0.92	$184.00	166,866
9/26/2023	David J Katzoff	CFO	Buy	3,533	$2.85	$10,069.05	5,400
5/24/2023	Milton C. Ault III	Major Shareholder	Buy	1,200	$8.85	$10,620.00	25,533
4/28/2023	Stephan Jackman	CEO	Buy	2,466	$8.10	$19,974.60	3,033
3/22/2023	Lynne Fahey Mcgrath	Director	Buy	666	$6.45	$4,295.70	666
3/16/2023	Milton C. Ault III	Major Shareholder	Buy	266	$7.50	$1,995.00	737,000
2/15/2023	Milton C. Ault III	Major Shareholder	Buy	66	$9.00	$594.00	736,733
12/27/2022	Milton C. Ault III	Major Shareholder	Buy	60	$8.85	$531.00	736,460
11/18/2022	Milton C. Ault III	Major Shareholder	Buy	66	$19.35	$1,277.10	735,866
10/31/2022	Milton C. Ault III	Major Shareholder	Buy	400	$17.85	$7,140.00	673,511
10/12/2022	Milton C. Ault III	Major Shareholder	Buy	133	$18.45	$2,453.85	673,111
10/6/2022	Milton C. Ault III	Major Shareholder	Buy	66	$21.45	$1,415.70	672,977
9/29/2022	Milton C. Ault III	Major Shareholder	Buy	233	$17.85	$4,159.05	672,911
9/19/2022	Stephan Jackman	CEO	Buy	566	$18.45	$10,442.70	566
9/14/2022	David J Katzoff	CFO	Buy	666	$16.65	$11,088.90	1,866
8/25/2022	Milton C. Ault III	Major Shareholder	Buy	326	$14.40	$4,694.40	667,171
8/22/2022	Milton C. Ault III	Major Shareholder	Buy	2,400	$14.55	$34,920.00	666,844
8/15/2022	Milton C. Ault III	Major Shareholder	Buy	933	$15.90	$14,834.70	663,444
8/3/2022	Milton C. Ault III	Major Shareholder	Buy	133	$14.25	$1,895.25	662,444
7/27/2022	Milton C. Ault III	Major Shareholder	Buy	380	$13.05	$4,959.00	662,311
7/22/2022	Milton C. Ault III	Major Shareholder	Buy	153	$13.65	$2,088.45	661,931
7/18/2022	Milton C. Ault III	Major Shareholder	Buy	666	$14.70	$9,790.20	661,777
6/29/2022	Milton C. Ault III	Major Shareholder	Buy	666	$13.20	$8,791.20	661,111
6/17/2022	Milton C. Ault III	Major Shareholder	Buy	666	$13.20	$8,791.20	660,444
6/14/2022	Milton C. Ault III	Major Shareholder	Buy	666	$12.75	$8,491.50	659,111
6/7/2022	Milton C. Ault III	Major Shareholder	Buy	133	$14.10	$1,875.30	657,911
6/2/2022	Milton C. Ault III	Major Shareholder	Buy	533	$14.40	$7,675.20	657,777
5/26/2022	Milton C. Ault III	Major Shareholder	Buy	666	$13.65	$9,090.90	656,444
5/24/2022	Milton C. Ault III	Major Shareholder	Buy	1,073	$13.35	$14,324.55	655,777
5/17/2022	Milton C. Ault III	Major Shareholder	Buy	1,593	$14.70	$23,417.10	654,371
5/12/2022	Milton C. Ault III	Major Shareholder	Buy	1,666	$12.75	$21,241.50	652,777
5/5/2022	Milton C. Ault III	Major Shareholder	Buy	6,666	$16.05	$106,989.30	21,666
4/26/2022	Milton C. Ault III	Major Shareholder	Buy	177,777	$22.50	$3,999,982.50	644,444
4/22/2022	Milton C. Ault III	Major Shareholder	Buy	5,000	$14.10	$70,500.00	15,000
4/11/2022	Milton C. Ault III	Major Shareholder	Buy	3,333	$16.95	$56,494.35	10,000
3/31/2022	Mark Gustafson	Director	Sell	1,333	$18.15	$24,193.95	4,000
3/18/2022	Milton C. Ault III	Major Shareholder	Buy	6,666	$16.50	$109,989.00
2/24/2022	Milton C. Ault III	Major Shareholder	Buy	1,500	$17.25	$25,875.00
1/27/2022	Milton C. Ault III	Major Shareholder	Buy	166	$21.00	$3,486.00
1/24/2022	Milton C. Ault III	Major Shareholder	Buy	333	$19.35	$6,443.55
1/18/2022	Milton C. Ault III	Major Shareholder	Buy	466	$24.90	$11,603.40
1/14/2022	Milton C. Ault III	Major Shareholder	Buy	200	$26.85	$5,370.00
1/7/2022	Milton C. Ault III	Major Shareholder	Buy	200	$28.95	$5,790.00
1/5/2022	Milton C. Ault III	Major Shareholder	Buy	133	$29.70	$3,950.10
12/23/2021	Milton C. Ault III	Major Shareholder	Buy	107	$31.50	$3,370.50
12/20/2021	Milton C. Ault III	Major Shareholder	Buy	1,666	$31.65	$52,728.90
12/17/2021	Milton C. Ault III	Major Shareholder	Buy	866	$37.20	$32,215.20
12/14/2021	Mark Gustafson	Director	Sell	1,333	$42.75	$56,985.75
11/30/2021	Milton C. Ault III	Major Shareholder	Buy	354	$34.05	$12,053.70
11/22/2021	Milton C. Ault III	Major Shareholder	Buy	1,000	$28.50	$28,500.00
11/8/2021	Milton C. Ault III	Major Shareholder	Buy	9,666	$38.55	$372,624.30
9/14/2021	Milton C. Ault III	Major Shareholder	Buy	333	$40.50	$13,486.50	10,000
8/27/2021	Milton C. Ault III	Major Shareholder	Buy	400	$43.50	$17,400.00
8/17/2021	Milton C. Ault III	Major Shareholder	Buy	266	$49.35	$13,127.10
8/12/2021	Milton C. Ault III	Major Shareholder	Buy	226	$58.05	$13,119.30
8/9/2021	Milton C. Ault III	Major Shareholder	Buy	33	$60.75	$2,004.75
8/6/2021	Milton C. Ault III	Major Shareholder	Buy	266	$61.05	$16,239.30
8/4/2021	Milton C. Ault III	Major Shareholder	Buy	33	$64.50	$2,128.50
8/2/2021	Milton C. Ault III	Major Shareholder	Buy	100	$68.40	$6,840.00
7/30/2021	Milton C. Ault III	Major Shareholder	Buy	89,222	$22.65	$2,020,878.30
7/26/2021	Milton C. Ault III	Major Shareholder	Buy	233	$74.10	$17,265.30
7/23/2021	Milton C. Ault III	Major Shareholder	Buy	333	$86.40	$28,771.20
7/19/2021	Milton C. Ault III	Major Shareholder	Buy	266	$81.15	$21,585.90
7/16/2021	Milton C. Ault III	Major Shareholder	Buy	40	$93.45	$3,738.00
7/14/2021	Milton C. Ault III	Major Shareholder	Buy	333	$101.10	$33,666.30
7/12/2021	Milton C. Ault III	Major Shareholder	Buy	540	$92.25	$49,815.00
7/8/2021	Milton C. Ault III	Major Shareholder	Buy	133	$91.20	$12,129.60
7/6/2021	Milton C. Ault III	Major Shareholder	Buy	466	$106.05	$49,419.30
6/28/2021	Milton C. Ault III	Major Shareholder	Buy	600	$144.15	$86,490.00
6/25/2021	Milton C. Ault III	Major Shareholder	Buy	933	$131.85	$123,016.05
6/22/2021	Milton C. Ault III	Major Shareholder	Buy	4,933	$139.35	$687,413.55

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

SEC Filings (Institutional Ownership Changes) for Alzamend Neuro (NASDAQ:ALZN)

49.61% of Alzamend Neuro stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Alzamend Neuro Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/2/2024	Truist Financial Corp	154,327	$0.14M	0.0%	-93.3%	2.168%
5/11/2022	RFG Advisory LLC	250,000	$0.31M	0.0%	N/A	0.277%
5/9/2022	Qube Research & Technologies Ltd	78,465	$97K	0.0%	N/A	0.087%
4/22/2022	Truist Financial Corp	2,314,907	$2.85M	0.0%	N/A	2.569%
1/31/2022	Commonwealth Equity Services LLC	116,666	$0.22M	0.0%	N/A	0.131%
11/16/2021	Schonfeld Strategic Advisors LLC	31,600	$97K	0.0%	N/A	0.036%
11/16/2021	Two Sigma Investments LP	172,913	$0.53M	0.0%	N/A	0.199%
11/16/2021	Warberg Asset Management LLC	14,000	$43K	0.0%	N/A	0.016%
11/15/2021	Sassicaia Capital Advisers LLC	93,762	$0.29M	0.8%	N/A	0.108%
9/17/2021	Virtu Financial LLC	15,402	$0.14M	0.0%	N/A	0.018%
8/16/2021	Cubist Systematic Strategies LLC	23,672	$0.21M	0.0%	N/A	0.028%
8/13/2021	Geode Capital Management LLC	44,600	$0.39M	0.0%	N/A	0.052%
8/11/2021	Susquehanna International Group LLP	57,030	$0.50M	0.0%	N/A	0.067%

Data available starting January 2016

Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002 stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Today's Range

Now: $0.73

$0.70

$0.74

50 Day Range

MA: $0.92

$0.68

$1.20

52 Week Range

Now: $0.73

$0.65

$11.91

Volume

13,934 shs

Average Volume

51,739 shs

Market Capitalization

$5.04 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.02

Who are the company insiders with the largest holdings of Alzamend Neuro?: Alzamend Neuro's top insider shareholders include:
Milton C Ault III (Director)
Milton C Ault III (Major Shareholder)
David J Katzoff (CFO)
Stephan Jackman (CEO)
Lynne Fahey Mcgrath (Director)
Learn More about top insider investors at Alzamend Neuro.